Ignite Creation Date:
2024-05-05 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 9:50 AM
Study NCT ID:
NCT00686387
Status:
UNKNOWN
Last Update Posted:
2011-04-12
First Post:
2008-05-26
Brief Title:
Establishment of a Brain and Spinal Tumor Tissue Bank
Sponsor:
Taipei Medical University WanFang Hospital
Organization:
Taipei Medical University WanFang Hospital
Study Overview
Official Title:
Establishment of a Brain and Spinal Tumor Tissue Bank and Clinical Data Repository for Identifying Molecular Markers of Clinical Outcome
Status:
UNKNOWN
Status Verified Date:
2011-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to establish a Brain and Spinal Tumor TissueSpecimen repository to serve as a resource for current and future scientific studies
Detailed Description:
Glioblastoma multiforme GBM is the most common and lethal primary Brain and Spinal Tumor in adults It is nearly uniformly fatal with a median survival of approximately one year despite modern treatment modalities Efforts to understand why some patients live longer or shorter than the average may provide insights into the biology of these neoplasms For years researchers have tried to identify independent predictors that could help in treatment planning With the recent interest in molecular biology and molecular genetics tumor markers are now being examined as potential predictors A marker that could predict tumor response to therapy the likelihood of recurrence and survival would thus be quite useful
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None